For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Flagship Pioneering Innovations V, Inc.

Calculating rank

USPTO Granted Patents = 36

% Expired Patents = 5.6

EPO Patents = 3

Forward Citations = 55

Loading Chart...

Loading Chart...

87 inventors (with patents filed for the assignee):

David Arthur Berry (11 out of 87 patents)

Avak Kahvejian (10 out of 32 patents)

Jordi Mata-Fink (7 out of 26 patents)

4. Jonathan Barry Hurov (7 out of 7 patents)

5. Laura Gabriela Lande (6 out of 6 patents)

6. Ignacio Martinez (6 out of 8 patents)

7. Barry Andrew Martin (6 out of 15 patents)

8. Maier Steve Avendano Amado (6 out of 6 patents)

9. Chengyi Jenny Shu (6 out of 6 patents)

10. John Patrick Casey, Jr (6 out of 15 patents)

11. Geoffrey Von Maltzahn (5 out of 104 patents)

12. Zachary Garo Armen (5 out of 5 patents)

13. George Huck Neubauer (5 out of 5 patents)

14. Julian Alexander Stanley (5 out of 5 patents)

15. Steven John Taylor (5 out of 7 patents)

Core Competencies:

Gene Expression

Cancer Treatments

Viral Particles

Cargo Delivery

Metabolic Disorders

Immune Modulation

Agricultural Compositions

Postbiotics

Plant Genetics

Autoimmune Disorders

Cell Delivery

Nucleotide Sequence Alteration

36 patents: Sort by Forward Citations

1. 12637693 - Anellosomes and methods of use (2026-05-26),

2. 12540337 - SURFACE-MODIFIED VIRAL PARTICLES AND MODULAR VIRAL PARTICLES (2026-02-03),

3. 12522823 - METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION (2026-01-13),

4. 12509683 - METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION (2025-12-30),

5. 12496274 - Compositions and methods for compartment-specific cargo delivery (2025-12-16),

6. 12378578 - Fusosome compositions and uses thereof (2025-08-05),

7. 12209246 - Methods of genetically altering a whole plant seed (2025-01-28),

8. 12171801 - Compositions and related methods for controlling vector-borne diseases (2024-12-24),

9. 12115178 - Acylated active agents and methods of their use for the treatment of autoimmune disorders (2024-10-15),

10. 12018049 - Compositions and related methods for controlling vector-borne diseases (2024-06-25),

11. 11998610 - Conjugates and methods of using the same (2024-06-04),

12. 11974574 - Compositions and related methods for modulating endosymbionts (2024-05-07),

13. 11951154 - Compositions and methods for cell delivery (2024-04-09),

14. 11903975 - Methods and compositions relating to chondrisomes from blood products (2024-02-20),

15. 11903974 - Methods and compositions relating to chondrisomes from cultured cells (2024-02-20),

Company Overview

Flagship Pioneering Innovations V, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development and commercialization of innovative life sciences technologies. The organization focuses on creating transformative solutions in healthcare, particularly in areas such as therapeutics, diagnostics, and synthetic biology. By leveraging cutting-edge research and fostering a collaborative environment, Flagship aims to address significant challenges in medicine and improve patient outcomes through pioneering advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

36 Patents

#79 in Cambridge, MA

#562 in Massachusetts

#9,521 in US

#18,756 in the World

Cambridge, MA, United States of America

Flagship Pioneering Innovations V, Inc.

Forward Citations = 55

87 inventors:

David Arthur Berry (11 out of 87 patents)

Avak Kahvejian (10 out of 32 patents)

Jordi Mata-Fink (7 out of 26 patents)

4. Jonathan Barry Hurov (7 out of 7 patents)

5. Laura Gabriela Lande (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Flagship Pioneering Innovations V, Inc.. Retrieved from https://idiyas.com/company/flagship-pioneering-innovations-v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…